Investment

Invest in Xero Picks

Join our WeFunder community Early Bird round and be among the first to access exclusive investment opportunities in Xero Picks.

As an early supporter, you’ll gain priority access to deals before they’re publicly available, receive early notifications, and benefit from premium insights curated by our expert team.

This is your chance to invest in a disruptive brand at the forefront of innovation—don’t miss it. Be part of our mission and grow with us.Secure your spot today and stay ahead of the curve.

Please enter your name and email address, and we’ll redirect you to our WeFunder campaign.

Help us change the World!

The primary purpose of this campaign is to file an ANDA "Amended New Drug Application" for an OTC "Over the Counter Certificate" for Nicotine Cessation Device as our first non-prescription drug approval request. The approval would allow us to sell nicotine in any and Major Retail Chains like Walmart or online globally on Amazon as a cessation or replacement device. Thus, competing with the likes of ZYN & Nicorette in a global nicotine pouch & gum market which are expected to grow from $1.63 billion in 2023 to $2.55 billion by 2032.